Literature DB >> 26293621

High frequency of mismatch repair deficiency among pediatric high grade gliomas in Jordan.

Nisreen Amayiri1, Uri Tabori2,3,4, Brittany Campbell2,3, Doua Bakry2,3, Melyssa Aronson5, Carol Durno5,6, Patricia Rakopoulos7, David Malkin2,3, Ibrahim Qaddoumi8, Awni Musharbash9, Maisa Swaidan10, Eric Bouffet2,3, Cynthia Hawkins7, Maysa Al-Hussaini11.   

Abstract

Biallelic mismatch repair deficiency (bMMRD) is a cancer predisposition syndrome affecting primarily individuals from consanguinous families resulting in multiple childhood cancers including high grade gliomas (HGG). This is the first study to assess the prevalence of bMMRD among patients with HGG in countries where consanguinity is high. We collected molecular and clinical information on all children diagnosed with HGG and supratentorial primitive neuroectodermal tumors (sPNET) between 2003 and 2013 at King Hussein Cancer Center, Jordan. Comparison was made to a similar cohort from Toronto. Clinical data regarding presence of café au lait macules(CAL), family history of cancer, consanguinity, pathology and treatment were collected. Tumors were centrally reviewed and tested for MMRD by immunohistochemistry of the corresponding proteins. Forty-two patients fulfilled the inclusion criteria, including 36 with HGG. MMRD was observed in 39% of HGG of whom 79% also lost MMR staining in the corresponding normal cells suggestive of bMMRD. P53 dysfunction was highly enriched in MMR deficient tumors (p = 0.0003).The frequency of MMRD was significantly lower in Toronto cohort (23%, p = 0.03). Both evidence of CAL and consanguinity correlated with bMMRD (p = 0.005 and 0.05,respectively) but family history of cancer didn't. HGG with all three bMMRD risk factors had evidence of MMRD and all children affected by multiple bMMRD related cancers had identical gene loss by immunohistochemical staining. In Jordan, the frequency of clinical and immunohistochemical alterations suggestive of bMMRD in pediatric HGG is high. Genetic testing will enable appropriate counseling and cancer screening to improve survival of these patients.
© 2015 UICC.

Entities:  

Keywords:  biallelic mismatch repair deficiency; café au lait macules; consanguinity; high grade glioma; low income countries

Mesh:

Year:  2015        PMID: 26293621     DOI: 10.1002/ijc.29724

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

1.  Synchronous glioblastoma and medulloblastoma in a child with mismatch repair mutation.

Authors:  Nisreen Amayiri; Maysa Al-Hussaini; Maisa Swaidan; Imad Jaradat; Monther Qandeel; Uri Tabori; Cynthia Hawkins; Awni Musharbash; Khulood Alsaad; Eric Bouffet
Journal:  Childs Nerv Syst       Date:  2015-08-21       Impact factor: 1.475

2.  Hereditary brain tumor with a homozygous germline mutation in PMS2: pedigree analysis and prenatal screening in a family with constitutional mismatch repair deficiency (CMMRD) syndrome.

Authors:  Shahid Mahmood Baig; Ambrin Fatima; Muhammad Tariq; Tahir Naeem Khan; Zafar Ali; Mohammad Faheem; Humera Mahmood; Patrick Killela; Matthew Waitkus; Yiping He; Fangping Zhao; Sizhen Wang; Yuchen Jiao; Hai Yan
Journal:  Fam Cancer       Date:  2019-04       Impact factor: 2.375

Review 3.  Applied Cancer Immunogenomics: Leveraging Neoantigen Discovery in Glioblastoma.

Authors:  Tanner M Johanns; Gavin P Dunn
Journal:  Cancer J       Date:  2017 Mar/Apr       Impact factor: 3.360

4.  Comprehensive Analysis of Hypermutation in Human Cancer.

Authors:  Brittany B Campbell; Nicholas Light; David Fabrizio; Matthew Zatzman; Fabio Fuligni; Richard de Borja; Scott Davidson; Melissa Edwards; Julia A Elvin; Karl P Hodel; Walter J Zahurancik; Zucai Suo; Tatiana Lipman; Katharina Wimmer; Christian P Kratz; Daniel C Bowers; Theodore W Laetsch; Gavin P Dunn; Tanner M Johanns; Matthew R Grimmer; Ivan V Smirnov; Valérie Larouche; David Samuel; Annika Bronsema; Michael Osborn; Duncan Stearns; Pichai Raman; Kristina A Cole; Phillip B Storm; Michal Yalon; Enrico Opocher; Gary Mason; Gregory A Thomas; Magnus Sabel; Ben George; David S Ziegler; Scott Lindhorst; Vanan Magimairajan Issai; Shlomi Constantini; Helen Toledano; Ronit Elhasid; Roula Farah; Rina Dvir; Peter Dirks; Annie Huang; Melissa A Galati; Jiil Chung; Vijay Ramaswamy; Meredith S Irwin; Melyssa Aronson; Carol Durno; Michael D Taylor; Gideon Rechavi; John M Maris; Eric Bouffet; Cynthia Hawkins; Joseph F Costello; M Stephen Meyn; Zachary F Pursell; David Malkin; Uri Tabori; Adam Shlien
Journal:  Cell       Date:  2017-10-19       Impact factor: 41.582

5.  Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors.

Authors:  Deborah T Blumenthal; Michal Yalon; Gilad W Vainer; Alexander Lossos; Shlomit Yust; Lior Tzach; Emanuela Cagnano; Dror Limon; Felix Bokstein
Journal:  J Neurooncol       Date:  2016-07-04       Impact factor: 4.130

6.  Durable Response to Nivolumab in a Pediatric Patient with Refractory Glioblastoma and Constitutional Biallelic Mismatch Repair Deficiency.

Authors:  Musa AlHarbi; Nahla Ali Mobark; Latifa AlMubarak; Rasha Aljelaify; Mariam AlSaeed; Amal Almutairi; Fatmah Alqubaishi; M Emarat Hussain; Ali Abdullah O Balbaid; Amal Said Marie; Lamia AlSubaie; Saeed AlShieban; Nada alTassan; Shakti H Ramkissoon; Malak Abedalthagafi
Journal:  Oncologist       Date:  2018-08-13

Review 7.  The Challenge of Diagnosing Constitutional Mismatch Repair Deficiency Syndrome in Brain Malignancies from Young Individuals.

Authors:  Cristina Carrato; Carolina Sanz; Ana María Muñoz-Mármol; Ignacio Blanco; Marta Pineda; Jesús Del Valle; Estela Dámaso; Manel Esteller; Eva Musulen
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

8.  Immune Checkpoint Inhibition as Primary Adjuvant Therapy for an IDH1-Mutant Anaplastic Astrocytoma in a Patient with CMMRD: A Case Report-Usage of Immune Checkpoint Inhibition in CMMRD.

Authors:  Rebekah Rittberg; Craig Harlos; Heidi Rothenmund; Anirban Das; Uri Tabori; Namita Sinha; Harminder Singh; Bernie Chodirker; Christina A Kim
Journal:  Curr Oncol       Date:  2021-02-01       Impact factor: 3.677

Review 9.  Pediatric High Grade Gliomas in the Context of Cancer Predisposition Syndromes.

Authors:  Orli Michaeli; Uri Tabori
Journal:  J Korean Neurosurg Soc       Date:  2018-05-01

10.  Role of video capsule endoscopy in patients with constitutional mismatch repair deficiency (CMMRD) syndrome: report from the International CMMRD Consortium.

Authors:  Y Shimamura; C M Walsh; S Cohen; M Aronson; U Tabori; P P Kortan; C A Durno
Journal:  Endosc Int Open       Date:  2018-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.